Galapagos NV
GLPG
#4625
Rank
S$2.64 B
Marketcap
S$40.20
Share price
-1.51%
Change (1 day)
10.82%
Change (1 year)

Market capitalization of Galapagos NV (GLPG)

Market cap: S$2.64 Billion

As of December 2025 Galapagos NV has a market cap of S$2.64 Billion. This makes Galapagos NV the world's 4625th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Galapagos NV from 2008 to 2025

End of year Market Cap

Year Marketcap Change
2025S$2.64 B8.34%
2024S$2.44 B-30.88%
2023S$3.53 B-9.68%
2022S$3.91 B-20.69%
2021S$4.93 B-42.35%
2020S$8.56 B-52.97%
2019S$18.21 B165.62%
2018S$6.85 B6.75%
2017S$6.42 B48.94%
2016S$4.31 B23.69%
2015S$3.48 B362.39%
2014S$0.75 B-5.03%
2013S$0.79 B14.9%
2012S$0.69 B49.61%
2011S$0.46 B-15.71%
2010S$0.54 B53.14%
2009S$0.35 B143.5%
2008S$0.14 B

End of Day market cap according to different sources

On Dec 14th, 2025 the market cap of Galapagos NV was reported to be:

S$2.69 Billion
by Nasdaq info icon info icon
S$2.69 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
AstraZeneca
AZN
S$364.01 B 13,640.11%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
S$662.89 B 24,921.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$149.44 B 5,541.08%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
S$518.28 B 19,463.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
S$0.13 B-95.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$286.84 B 10,727.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$44.29 B 1,571.85%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
S$128.06 B 4,733.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
S$322.54 B 12,074.68%๐Ÿ‡บ๐Ÿ‡ธ USA